Dynavax Technologies stock (US2681581009): vaccine specialist in focus after latest pipeline and ear - AD HOC NEWS
Dynavax Technologies stock (US2681581009): vaccine specialist in focus after latest pipeline and ear AD HOC NEWS
Dynavax Technologies stock (US2681581009): vaccine specialist in focus after latest pipeline and ear AD HOC NEWS
Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress Frontiers
T cell immunity in vaccination and disease Nature
mRNA: the vaccine revolution British Society for Immunology
One vaccine may provide broad protection against many respiratory infections and allergens Stanford Medicine
New vaccine strategy could help extend immunity against evolving viruses UW–Madison News
Sex differences in immune responses to viruses, bacteria and vaccines Nature
Annual meeting of experts at UT San Antonio promotes advances in infectious disease, immunology and vaccines UT San Antonio Today
Vaccination in the post-COVID era: lessons to be learned in Latin America Frontiers
‘Universal vaccine’ protects mice against multiple pathogens Nature
COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes Science | AAAS
Why Vaccines Are Especially Important If You Have Asthma or Allergies American College of Allergy Asthma and Immunology
Vaccine symposium airs multiple ideas for accelerating preventive immunology Stanford Medicine
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms Nature
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response Frontiers
Melioidosis vaccines: recent advances and future directions Frontiers
Cancer vaccines as enablers of immunotherapy Nature
A guide to vaccinology: from basic principles to new developments Nature
Eliciting antitumor immunity via therapeutic cancer vaccines Nature
Targets of protective immunity and opportunities in hepatitis C virus vaccine development Nature
Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows Stanford Medicine
T cells responses after vaccination: a regulatory perspective Frontiers
New Horizons for Immunology and Vaccine Research at Cincinnati Children’s Research Horizons
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice Nature
Artificial intelligence in vaccine research and development: an umbrella review Frontiers
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans Nature
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies Frontiers
An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses Science | AAAS
Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives Frontiers
Covid-19 Vaccines — Immunity, Variants, Boosters The New England Journal of Medicine
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults Nature
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants Frontiers
Stanford Medicine researchers can predict who will develop immunity from vaccination Stanford Medicine
Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2 Nature
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans Nature
Vaccination against rapidly evolving pathogens and the entanglements of memory Nature
Editorial: Systems immunology to advance vaccine development Frontiers
Precision Vaccine Development: Cues From Natural Immunity Frontiers
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses Nature
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV Frontiers